I would say it is kind of embarrassing to even consider
I would say it is kind of embarrassing to even consider such a 13d group. Have they not shown who they really are to everyone and their brother? The informed investor know who they are. Is there any doubt in their honesty? Definitely full of lies and smoke and mirrors in their path getting to this point. Can we trust their path forward. Are we sure they will do what they say they will do? Can we even believe anything they say? Do we typically follow dishonest leaders? I know… I do not follow someone who lies to me. The old sayin holds true for me… Fool me once and shame on you… Fool me twice and shame on me… They admitted their lies recently. Have we not all have been fooled at least once by their own admissions in their settlement of all the misinformation and outright lies they had to come clean on to settle the first lawsuit. Do you still trust this group? Why would you? What makes you trust a group that has lied to you? Do we forgive their lies? How do you forgive them? How do you trust them in the future?
Are they good leaders when they can’t decide proper priorities of which direction is needed for our company to be successful? When you can not figure out what direction to progress the company or which indications should be first… do we follow this 13d groups possible mismanagement? Will we really only have one trial indication at a time? How destructive would it be to stop all other trials and just focus on an arrogant doctors swan song trial only. When we have at minimal costs continuing all trials and potential revenue much sooner. Long haulers has its place and as soon as we can start the trial the better. But it is ignorance to stop our other trials. To wait until we get revenue from Long Haulers could bury us in dilution or maybe just bankrupt us. Is bankruptcy their true plan? It would be the smart as a fox way of intentionally going to bankruptcy. One where shareholders have no recourse. Then the liquidation sale they won’t speak too. Why won’t they address the claim? Can’t admit it now if this is their underlying plan or they do face shareholders recourse.
Having more irons in the fire is just good business and our management is doing everything right with the right priorities. Does the 13d group think that their path is sellable to the investors? They are not very convincing with a huge bet put on Long Haulers to be our first approval of any kind. Does this not mean we will stop all other trials that could achieve approval of some kind before Long haulers. Does this seem like an intelligent path?
Let’s compare our current management. Will they continue to be able to finance our trials until we receive our first approval? There is no doubt or very little risk. How soon could we see an approval on our managements path foreword? Maybe as son as 2-3 months. Will we continue all of our current trials? I believe that is our path and superior choice of direction forward. Has our current management told of us of our long term future? Yes they have. The 13d group has not committed to a long term future direction for our company. This is a serious flaw for them. Our current management has told us their long term plan is to grow our company into our own pharmaceutical company. Do not underestimate just how important this future is. There is not a better plan that we could have. The most return on our investment is growing into our own big pharmaceutical company and their is no argument about this. Becoming our own big Pharma is the best option we have to see the wealth of what our investment can do for us.
The 13d group gave us a 2 year plan with possible approval on Long Haulers. We all hope that Long Haulers is huge but do we bet our whole investment on it? We don’t know if they understand financing needed to continue our path forward to approval. The finance guy did not impress in his segment of the last call. Financing would be everything for them if we had to wait as long as two years for an approval on Long Haulers. They have not said definitively that they could receive a EUA for Long Haulers. Ohm says it’s not possible. Then can we wait almost two years for an approval?
Have I provided enough doubt about the 13d group to scare you? If your not scared now… you don’t have enough invested to become scared. Those of us that do are scared shitless of this unproven, lying, un-trustable inexperienced group. They have never ran a biotech company or a pharmaceutical company. They won’t tell you who the interim CEO will be? Why is that? It will cost them dearly in votes is why. My bet it is the less than believable Rosenbaum himself. If this isn’t a self destruction mode of a company to appoint a CEO of his unqualified experience. What a joke this would be. Ask yourself who else it would be? It’s not Patterson. He is the new CMO in their plan. Ask yourself why no CEO yet. Yep… more smoke and mirrors…more lies to come…
It’s just a rant that I have to speak to or it builds up inside of me and just flat pisses me off. Screw that 13d group and the horse they rode in on! Vote our current management and become rich for it.
There… is there any doubt in which way I lean?
16
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Celebration with Heart Ah, the classic mix of business and community goodwill—that's what Life Flower Dispensary is all about this year. You know, not every business that hits the 16-year mark decides to make it about something bigger than just slashing prices or hyping themselves up. But Life Flower? They're using their anniversary to throw a shindig that's more than...
Continue Reading
One Year Down, A Unique Path Forward It's been a year since Drunk Angel jumped into the online jewelry scene, and they're setting themselves apart in their own glittery lane. Imagine starting a brand that's not just about pretty trinkets, but about linking those tiny treasures to timeless traditions. They've got their sights set on blending the deep tales of gemstones...
Continue Reading
Series C Funding Ignites BrightPlan's Ambitions Ever seen a company that's ready to roll with the punches and come out stronger? That's BrightPlan for you. They're pushing the boundaries again, bagging new capital in this Series C round, steered by the seasoned folks over at ABS Capital Partners. Now, here's the thing: We're talking about a 230% revenue surge over just...
Continue Reading
A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...
Continue Reading
The Big Move in Correctional Healthcare VitalCore Health Strategies has made an impressive move with the opening of a 60-bed Behavioral Health Unit at Shawnee County Jail in Topeka, Kansas. The unit, part of a $21 million expansion completed on August 24, is set to change the landscape for inmates needing mental health and substance use treatment. This isn't just a slap...
Continue Reading
Transforming Old to New on the Runway Right when you think fashion's all about the next shiny thing, here comes Goodwill of Delaware & Delaware County flipping the script. Their ReThink Fashion Show - the ECO Edit teaches us a thing or two about what giving old clothes a new life truly means. It's not just about tossing a used tee onto a catwalk but a whole rebirth...
Continue Reading
Pioneering AI Innovations in Language Translation Timekettle is making some serious waves at IFA 2026, throwing its hat in the ring with innovations that redefine multilingual interaction. From sleek translation earbuds to full-blown meeting hubs, each gadget screams one thing loud and clear—communication sans language barriers. Centered in the tech extravaganza of...
Continue Reading
Verdafero's Latest Milestone: A Broader Environmental Reach It’s a day like today that makes you pause and realize that businesses in the hospitality space aren’t just about fluff and fancy lobbies anymore. They've got a new wave of responsibilities, especially with the globe pretty much on fire, literally and figuratively. Verdafero, a name not new to function and...
Continue Reading
Innovative Excellence in Healthcare Tech It's not every day you see a specialty group purchasing organization like AllyGPO snagging a spot on Fast Company's esteemed list of Best Workplaces for Innovators. Making it into the top half at number 40 in 2026, it’s a testament to a company really leaning into employee-driven innovation. And, buddy, this ain't just corporate...
Continue Reading
Glass & Vinyl Ambitions: A New Chapter Who would have guessed? The seasoned window maker Showcase Window and Door Company is putting its prime manufacturing facility up for grabs. The online auction, orchestrated by Tiger Group, kicks off September 10, and it's sure to stir up some excitement in the industry. With picking up operations now within reach, it feels like...
Continue Reading
Top 5 Most Recently Viewed Articles
Celebrating Customer Satisfaction: Flexibility Capital's Achievement Flexibility Capital, a provider of innovative financing solutions for small businesses, has joyfully announced a significant milestone — reaching 1,000 reviews on Trustpilot with an impressive Trustscore of 4.9 out of 5. This remarkable achievement solidifies Flexibility Capital's standing as a leading...
Continue Reading
Coherent Corp. Showcasing Innovations at OFC 2025 Coherent Corp. (NYSE: COHR), a trailblazer in the photonics sector, is gearing up to display its groundbreaking technologies and products dedicated to the future of optical communications. This exciting event will take place at OFC 2025. New Product Highlights Coherent is thrilled to present a suite of innovative products...
Continue Reading
Innovative Urban Solutions from Taiwan's Smart City Summit Participants from around the globe came together in Taipei for the 12th Smart City Summit & Expo and the 3rd Net-Zero City Expo, marking a significant step towards enhancing urban living. This prestigious event showcased Taiwan's commitment to technology and sustainability through its "Smart Nation 2.0"...
Continue Reading
Vishay Intertechnology's Strategic Restructuring for Growth Vishay Intertechnology, Inc. (NYSE: VSH), a prominent manufacturer of discrete semiconductors and passive components, is embarking on a major restructuring effort as part of its Vishay 3.0 growth initiative. This strategic decision aims to boost operational efficiency and solidify its position in the market....
Continue Reading
Jimmy Carter's Economic Challenges and Solutions Former President Jimmy Carter passed away at the remarkable age of 100, leaving behind a profound legacy. Throughout his presidency, he faced numerous economic hurdles that included inflation spikes, high-interest rates, and a significant energy crisis. These challenges highlighted his unique approach to governance and...
Continue Reading